These medications, originally designed for type 2 diabetes and now widely used for weight management, are often described as "game-changers." However, if you are managing a thyroid condition like Hashimotos thyroiditis or hypothyroidism, or if you have concerns about a family history of thyroid nodules, you likely have questions
Estradiol inhibits NPY/AgRP neurons primarily through glutamate and -endorphin release (84)
States Offering Broad GLP-1 Coverage for Obesity: A total of 14 states, including California, Michigan, and Pennsylvania, provide Medicaid coverage for the most common GLP-1s approved for either Type 2 diabetes or obesity
This side effect is common, particularly when the medication is taken late in the day
Meaning the public serves as the guinea pigs